Literature DB >> 2817853

Intrarenal distribution of vancomycin in endotoxemic rats.

M Ngeleka1, P Auclair, D Tardif, D Beauchamp, M G Bergeron.   

Abstract

We previously observed that the intrarenal distribution of aminoglycosides was modified by Escherichia coli endotoxin in the absence of any major renal physiological disturbance or histological changes. In the present study, we evaluated the role of E. coli endotoxin on the intrarenal distribution of vancomycin. At the beginning of the experiment, female Sprague-Dawley rats were infused intravenously with saline (control) or endotoxin (0.25 mg/kg) during 15 min. Thereafter, saline was constantly infused for the following 4 h. Two hours after the beginning of the infusion, animals were injected intravenously with a single dose of vancomycin (20 mg/kg). The drug levels in serum; renal cortex, medulla, and papilla; and urine were evaluated from 0.08 to 24 h after injection. Analysis of the area under the curve of the drug concentration in the different kidney components versus time showed a higher accumulation of vancomycin in the renal cortex and medulla in the endotoxin-infused rats than in the normal rats (P less than 0.01). Endotoxin was associated with an increase in the half-life in serum (P less than 0.01) and a lower elimination rate constant. The total clearance of vancomycin from plasma was significantly decreased in endotoxin-treated rats (P less than 0.01). These results demonstrate that endotoxin modifies the renal handling of vancomycin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817853      PMCID: PMC172705          DOI: 10.1128/AAC.33.9.1575

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Toxicity, clearance, and metabolic effects of pactamycin in combination with bacterial lipopolysaccharide.

Authors:  S G Bradley; J S Bond
Journal:  Toxicol Appl Pharmacol       Date:  1975-02       Impact factor: 4.219

2.  Mechanisms of the hemodynamic effects of endotoxin.

Authors:  R P GILBERT
Journal:  Physiol Rev       Date:  1960-04       Impact factor: 37.312

3.  Effects of vancomycin on renal function in rats.

Authors:  G R Aronoff; R S Sloan; C B Dinwiddie; M D Glant; N S Fineberg; F C Luft
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

4.  Experimental lipid A-induced nephritis in the dog.

Authors:  M Westenfelder; C Galanos; P O Madsen
Journal:  Invest Urol       Date:  1975-03

5.  Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis.

Authors:  J L Shenep; K A Mogan
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

6.  Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin.

Authors:  M G Bergeron; Y Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

7.  Toxicology of vancomycin in laboratory animals.

Authors:  J S Wold; S A Turnipseed
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

8.  Disturbed intrarenal distribution of gentamicin in experimental pyelonephritis due to Escherichia coli.

Authors:  M G Bergeron; S Trottier; C Lessard; D Beauchamp; P M Gagnon
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

9.  Vancomycin enhancement of experimental tobramycin nephrotoxicity.

Authors:  C A Wood; S J Kohlhepp; P W Kohnen; D C Houghton; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

10.  A prospective study of adverse reactions associated with vancomycin therapy.

Authors:  T C Sorrell; P J Collignon
Journal:  J Antimicrob Chemother       Date:  1985-08       Impact factor: 5.790

View more
  2 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 2.  Review of vancomycin-induced renal toxicity: an update.

Authors:  Oluwatoyin Bamgbola
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-30       Impact factor: 3.565

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.